Bioluminescent virion shells: New tools for quantitation of AAV vector dynamics in cells and live animals

Gene Therapy

Volumn 15, Issue 24, 2008, Pages 1618-1622

  Asokan, A ^a   Johnson, J S ^a   Li, C ^a   Samulski, R J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AMINO TERMINAL SEQUENCE; ARTICLE; BIOLUMINESCENCE; CELL SURFACE; EPITHELIUM CELL; GENETIC ENGINEERING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROTYPE; TREND STUDY; VIRION; VIRUS CAPSID;

ANIMALS; CAPSID; DEPENDOVIRUS; DNA, RECOMBINANT; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HINDLIMB; HUMANS; INJECTIONS, INTRAMUSCULAR; LUCIFERASES; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; VIRION; VIRUS ASSEMBLY;

ANIMALIA; MAMMALIA; MIRIDAE;

EID: 57049099821     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.127     Document Type: Article

References (24)

1. Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Mol Ther 2006; 14: 316-327.
2. Warrington Jr KH, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J Virol 2004; 78: 6595-6609.
3. Lux K, Goerlitz N, Schlemminger S, Perabo L, Goldnau D, Endell J et al. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking. J Virol 2005; 79: 11776-11787.
4. Swenson ES, Price JG, Brazelton T, Krause DS. Limitations of green fluorescent protein as a cell lineage marker. Stem Cells 2007; 25: 2593-2600.
5. Tam JM, Upadhyay R, Pittet MJ, Weissleder R, Mahmood U. Improved in vivo whole-animal detection limits of green fluorescent protein-expressing tumor lines by spectral fluorescence imaging. Mol Imaging 2007; 6: 269-276.
6. Yaghoubi SS, Berger F, Gambhir SS. Studying the biodistribution of positron emission tomography reporter probes in mice. Nat Protoc 2007; 2: 1752-1755.
7. Piwnica-Worms D, Schuster DP, Garbow JR. Molecular imaging of host-pathogen interactions in intact small animals. Cell Microbiol 2004; 6: 319-331.
8. Rose JA, Maizel Jr JV, Inman JK, Shatkin AJ. Structural proteins of adenovirus-associated viruses. J Virol 1971; 8: 766-770.
9. Verhaegent M, Christopoulos TK. Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal Chem 2002; 74: 4378-4385.
10. Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 2005; 11: 435-443.
11. Grieger JC, Samulski RJ. Packaging capacity of adeno-associated virus serotypes: Impact of larger genomes on infectivity and postentry steps. J Virol 2005; 79: 9933-9944.
12. Grieger JC, Choi VW, Samulski RJ. Production and characterization of adeno-associated viral vectors. Nat Protoc 2006; 1: 1412-1428.
13. Negishi A, Chen J, McCarty DM, Samulski RJ, Liu J, Superfine R. Analysis of the interaction between AAV and heparan sulfate using atomic force microscopy. Glycobiology 2004; 14: 969-977.
14. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
15. Kolokoltsov AA, Davey RA. Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay. J Virol 2004; 78: 5124-5132.
16. Hauck B, Xiao W. Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol 2003; 77: 2768-2774.
17. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801.
18. Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 2005; 23: 321-328.
19. Rabinowitz JE, Bowles DE, Faust SM, Ledford JG, Cunningham SE, Samulski RJ. Cross-dressing the virion: The transcapsidation of AAV serotypes functionally defines subgroups. J Virol 2004; 78: 4421-4432.
20. Pruchnic R, Cao B, Peterson ZQ, Xiao X, Li J, Samulski RJ et al. The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. Hum Gene Ther 2000; 11: 521-536.
21. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302-317.
22. Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L et al. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 2007; 18: 195-206.
23. Di Pasquale G, Chiorini JA. AAV transcytosis through barrier epithelia and endothelium. Mol Ther 2006; 13: 506-516.
24. Matthews QL, Sibley DA, Wu H, Li J, Stoff-Khalili MA, Waehler R et al Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion. Mol Imaging 2006; 5: 510-519.